Clinical studies recruiting near Fort Collins

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

Testing the Addition of High Dose, Targeted Radiation to the Usual Treatment for Locally-Advanced Inoperable Non-Small C
Phase 3 · Poudre Valley Hospital · NRG Oncology · NCT05624996 Using Biomarker Tests to Select and Test New, Personalized Treatments for Extensive Stage Small Cell Lung Cancer, PRISM
Phase 2 · Poudre Valley Hospital · SWOG Cancer Research Network · NCT06769126 Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
Phase 2/Phase 3 · Poudre Valley Hospital · NRG Oncology · NCT05174169 ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathol
Phase 3 · Poudre Valley Hospital · Alliance for Clinical Trials in Oncology · NCT06876714 Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and S
Phase 3 · Poudre Valley Hospital · Canadian Cancer Trials Group · NCT06592924 Influence of the Gut Microbiome on Blueberry Polyphenol Metabolites
NA · Colorado State University; Food and Nutrition Clinical Resea · Colorado State University · NCT07607158 Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial
Phase 2 · Poudre Valley Hospital · Alliance for Clinical Trials in Oncology · NCT06632977 Combining Immunotherapy and Radiation Therapy to Help Patients Avoid Bladder Removal After Treatment Shrinks Muscle Inva
Phase 2 · Poudre Valley Hospital · National Cancer Institute (NCI) · NCT07061964 Testing the Addition of Stereotactic Radiation Therapy With Immune Therapy for the Treatment of Patients With Unresectab
Phase 2 · Poudre Valley Hospital · NRG Oncology · NCT05327686 De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Eq
Phase 3 · Poudre Valley Hospital · NRG Oncology · NCT04852887 mFOLFIRINOX Versus mFOLFOX With or Without Nivolumab for the Treatment of Advanced, Unresectable, or Metastatic HER2 Neg
Phase 3 · Poudre Valley Hospital · Alliance for Clinical Trials in Oncology · NCT05677490 Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With
Phase 3 · Poudre Valley Hospital · National Cancer Institute (NCI) · NCT07198074 Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide,
Phase 3 · Poudre Valley Hospital · National Cancer Institute (NCI) · NCT06058377 Testing the Role of DNA Released From Tumor Cells Into the Blood in Guiding the Use of Immunotherapy After Surgical Remo
Phase 2/Phase 3 · Poudre Valley Hospital · National Cancer Institute (NCI) · NCT05987241 Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The Co
Phase 2 · Poudre Valley Hospital · National Cancer Institute (NCI) · NCT05564377 A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab
Phase 3 · Poudre Valley Hospital · National Cancer Institute (NCI) · NCT05675410 Measuring if Immunotherapy Plus Chemotherapy is Better Than Chemotherapy Alone for Patients With Aggressive Poorly Diffe
Phase 3 · Poudre Valley Hospital · National Cancer Institute (NCI) · NCT06422806 BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or S
Phase 2 · Poudre Valley Hospital · National Cancer Institute (NCI) · NCT05136196 Comparing Rituximab and Mosunetuzumab Drug Treatments for People With Low Tumor Burden Follicular Lymphoma
Phase 3 · Poudre Valley Hospital · National Cancer Institute (NCI) · NCT06337318 Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung
Phase 3 · Poudre Valley Hospital · National Cancer Institute (NCI) · NCT04267848 Testing Immunotherapy With or Without Stereotactic Body Radiation Therapy in Patients With Advanced Liver Cancer, HELIO-
Phase 3 · Poudre Valley Hospital · NRG Oncology · NCT07166406 Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
Phase 2/Phase 3 · Poudre Valley Hospital · SWOG Cancer Research Network · NCT03851445 The Vanguard Study: Testing a New Way to Screen for Cancer
NA · Poudre Valley Hospital · National Cancer Institute (NCI) · NCT06995898 A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer
NA · Poudre Valley Hospital · NRG Oncology · NCT04251052 Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
Phase 3 · Poudre Valley Hospital · NRG Oncology · NCT06580314 Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer That Has EGFR and MET Gene Changes (A L
Phase 2 · Poudre Valley Hospital · SWOG Cancer Research Network · NCT05642572 Active Surveillance, Bleomycin, Etoposide, Carboplatin or Cisplatin in Treating Pediatric and Adult Patients With Germ C
Phase 3 · Poudre Valley Hospital · Children's Oncology Group · NCT03067181 Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has Increased Copies of the MET Gene (An Expanded Lung-M
Phase 2 · Poudre Valley Hospital · SWOG Cancer Research Network · NCT06116682 Testing the Addition of Anti-Cancer Drug, Cetuximab, to Standard of Care Treatment (Pembrolizumab) for Returning or Spre
Phase 3 · Poudre Valley Hospital · National Cancer Institute (NCI) · NCT06589804 A Study to Evaluate Different Targeted Therapies for Patients With Rheumatoid Arthritis
Phase 2 · Tekton Research - Fort Collins - East Harmony Road /ID# 2724 · AbbVie · NCT06972446

Look up another city

Look up another condition